These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 29222657)
1. Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells. Zeng J; Zhang Y; Ruan J; Yang Z; Wang C; Hong Z; Zuo Z Environ Sci Pollut Res Int; 2018 Feb; 25(6):5582-5589. PubMed ID: 29222657 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231. Rwigemera A; Mamelona J; Martin LJ Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway. Rwigemera A; Mamelona J; Martin LJ Cell Biol Toxicol; 2014 Jun; 30(3):157-67. PubMed ID: 24760606 [TBL] [Abstract][Full Text] [Related]
4. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. Asai A; Sugawara T; Ono H; Nagao A Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942 [TBL] [Abstract][Full Text] [Related]
5. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263 [TBL] [Abstract][Full Text] [Related]
6. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment. Martin LJ Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004 [TBL] [Abstract][Full Text] [Related]
7. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166 [TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Matsumoto M; Hosokawa M; Matsukawa N; Hagio M; Shinoki A; Nishimukai M; Miyashita K; Yajima T; Hara H Eur J Nutr; 2010 Jun; 49(4):243-9. PubMed ID: 19888619 [TBL] [Abstract][Full Text] [Related]
9. Dual Biological Functions of a Cytoprotective Effect and Apoptosis Induction by Bioavailable Marine Carotenoid Fucoxanthinol through Modulation of the Nrf2 Activation in RAW264.7 Macrophage Cells. Taira J; Sonamoto M; Uehara M Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 28984834 [TBL] [Abstract][Full Text] [Related]
10. Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Konishi I; Hosokawa M; Sashima T; Kobayashi H; Miyashita K Comp Biochem Physiol C Toxicol Pharmacol; 2006; 142(1-2):53-9. PubMed ID: 16337836 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of fucoxanthin against ferric nitrilotriacetate-induced oxidative stress in murine hepatic BNL CL.2 cells. Liu CL; Liang AL; Hu ML Toxicol In Vitro; 2011 Oct; 25(7):1314-9. PubMed ID: 21569835 [TBL] [Abstract][Full Text] [Related]
12. The protective effects of Nile tilapia (Oreochromis niloticus) scale collagen hydrolysate against oxidative stress induced by tributyltin in HepG2 cells. Ruan J; Chen J; Zeng J; Yang Z; Wang C; Hong Z; Zuo Z Environ Sci Pollut Res Int; 2019 Feb; 26(4):3612-3620. PubMed ID: 30523527 [TBL] [Abstract][Full Text] [Related]
13. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. Sachindra NM; Sato E; Maeda H; Hosokawa M; Niwano Y; Kohno M; Miyashita K J Agric Food Chem; 2007 Oct; 55(21):8516-22. PubMed ID: 17894451 [TBL] [Abstract][Full Text] [Related]
14. Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma. Rokkaku T; Kimura R; Ishikawa C; Yasumoto T; Senba M; Kanaya F; Mori N Int J Oncol; 2013 Oct; 43(4):1176-86. PubMed ID: 23857515 [TBL] [Abstract][Full Text] [Related]
15. A novel strategy for isolation and purification of fucoxanthinol and fucoxanthin from the diatom Nitzschia laevis. Sun P; Wong CC; Li Y; He Y; Mao X; Wu T; Ren Y; Chen F Food Chem; 2019 Mar; 277():566-572. PubMed ID: 30502186 [TBL] [Abstract][Full Text] [Related]
16. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Kotake-Nara E; Asai A; Nagao A Cancer Lett; 2005 Mar; 220(1):75-84. PubMed ID: 15737690 [TBL] [Abstract][Full Text] [Related]
17. Fucoxanthin and Its Metabolite Fucoxanthinol Do Not Induce Browning in Human Adipocytes. Rebello CJ; Greenway FL; Johnson WD; Ribnicky D; Poulev A; Stadler K; Coulter AA J Agric Food Chem; 2017 Dec; 65(50):10915-10924. PubMed ID: 29172481 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry. Zhang Y; Wu H; Wen H; Fang H; Hong Z; Yi R; Liu R Mar Drugs; 2015 Oct; 13(10):6521-36. PubMed ID: 26512677 [TBL] [Abstract][Full Text] [Related]
19. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas. Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541 [TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. Tsukui T; Konno K; Hosokawa M; Maeda H; Sashima T; Miyashita K J Agric Food Chem; 2007 Jun; 55(13):5025-9. PubMed ID: 17536824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]